These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 9375697

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100,635 and GR 127,935.
    Gobert A, Rivet JM, Cistarelli L, Millan MJ.
    J Neurochem; 1997 Mar; 68(3):1159-63. PubMed ID: 9048762
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.
    Millan MJ, Newman-Tancredi A, Audinot V, Cussac D, Lejeune F, Nicolas JP, Cogé F, Galizzi JP, Boutin JA, Rivet JM, Dekeyne A, Gobert A.
    Synapse; 2000 Feb; 35(2):79-95. PubMed ID: 10611634
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptors.
    Gobert A, Billiras R, Cistarelli L, Millan MJ.
    J Neurosci Methods; 2004 Dec 30; 140(1-2):141-52. PubMed ID: 15589344
    [Abstract] [Full Text] [Related]

  • 14. Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat.
    Dawson LA, Li P.
    J Neural Transm (Vienna); 2003 Jun 30; 110(6):577-90. PubMed ID: 12768354
    [Abstract] [Full Text] [Related]

  • 15. Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats.
    Muneoka K, Shirayama Y, Takigawa M, Shioda S.
    Neurochem Res; 2009 Mar 30; 34(3):542-55. PubMed ID: 18751896
    [Abstract] [Full Text] [Related]

  • 16. Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release.
    Gobert A, Rivet JM, Audinot V, Newman-Tancredi A, Cistarelli L, Millan MJ.
    Neuroscience; 1998 May 30; 84(2):413-29. PubMed ID: 9539213
    [Abstract] [Full Text] [Related]

  • 17. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.
    Koch S, Hemrick-Luecke SK, Thompson LK, Evans DC, Threlkeld PG, Nelson DL, Perry KW, Bymaster FP.
    Neuropharmacology; 2003 Dec 30; 45(7):935-44. PubMed ID: 14573386
    [Abstract] [Full Text] [Related]

  • 18. Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats.
    Gobert A, Millan MJ.
    Neuropharmacology; 1999 Feb 30; 38(2):315-7. PubMed ID: 10218874
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.